| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 25 | XLO Xilio Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 44,250 | 0.00 | 244,883 |
| 1 Jan 25 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.955 | 638,000 | 609.29 k | 638,000 |
| 1 Jan 25 | XLO Xilio Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 44,250 | 0.00 | 132,750 |
| 1 May 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 474,000 | 511.92 k | 474,000 |
| 1 Jan 24 | XLO Xilio Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 177,000 | 0.00 | 177,000 |
| 16 Aug 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.785 | 700,000 | 1.95 mm | 700,000 |
